<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03758755</url>
  </required_header>
  <id_info>
    <org_study_id>18-3150</org_study_id>
    <nct_id>NCT03758755</nct_id>
  </id_info>
  <brief_title>Blood Flow Restriction Following ACL Reconstruction</brief_title>
  <acronym>BFR</acronym>
  <official_title>The Effect of Blood Flow Restriction Therapy Following Anterior Cruciate Ligament Reconstruction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Inova Health Care Services</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Inova Health Care Services</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective is to determine the impact of Blood Flow Restriction (BFR) therapy, in
      comparison to a standard rehabilitation protocol, on the functional outcomes of patients
      recovering from ACL reconstruction. The investigators hypothesize that patients undergoing
      BFR therapy after ACL reconstruction surgery will have better functional outcomes than those
      undergoing normal rehabilitation without BFR therapy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Recovery from anterior cruciate ligament (ACL) reconstruction involves early physical therapy
      to promote muscular development. Traditional training regimens are based on the concept that
      muscle growth is induced with high resistance exercises of at least 65-70% of 1-repetition
      maximum. Achieving a high resistance level can be challenging in the early post-surgical
      patient who may be limited by pain, muscle atrophy, diminished proprioception, and
      psychological factors. Increasing evidence has suggested that Blood Flow Restriction (BFR) in
      resistance training, while transmitting a decreased load (25-50% of 1-repetition maximum)
      across the surgical site, may provide an additional benefit of inducing muscular development
      similar to that of high intensity exercises .

      Augmenting exercises with BFR involves an external pressure cuff applied to the proximal
      portion of the extremity, which is inflated to a pressure that restricts venous outflow while
      allowing arterial inflow to continue. This creates a physiologic environment for the patient
      to gain the hypertrophic effect of high resistance training, though at a lower and safer
      intensity. Studies suggest that BFR stimulates muscular development through an increase in
      metabolic stress, muscle fiber recruitment, cell swelling, and protein synthesis.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2018</start_date>
  <completion_date type="Anticipated">November 2022</completion_date>
  <primary_completion_date type="Anticipated">November 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Knee Injury and Osteoarthritis Score (KOOS)</measure>
    <time_frame>Measured at 3 months post op</time_frame>
    <description>The Knee injury and Osteoarthritis Outcome Score (KOOS) is a patient-reported outcome measurement instrument, developed to assess the patient's opinion about their knee and associated problem. The KOOS collects data on five patient-centered outcomes. The five patient-relevant subscales of KOOS are scored separately: KOOS Pain (9 items); KOOS Symptoms (7 items); KOOS ADL (17 items); KOOS Sport/Rec (5 items); KOOS QOL (4 items). A Likert scale is used and all items have five possible answer options scored from 0 (No Problems) to 4 (Extreme Problems) and each of the five scores is calculated as the sum of the items included. Scores are transformed to a 0-100 scale, with zero representing extreme knee problems and 100 representing no knee problems as is common in orthopaedic assessment scales and generic measures. Scores between 0 and 100 represent the percentage of total possible score achieved.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Knee Injury and Osteoarthritis Score (KOOS)</measure>
    <time_frame>Measured at 6 months post op</time_frame>
    <description>The Knee injury and Osteoarthritis Outcome Score (KOOS) is a patient-reported outcome measurement instrument, developed to assess the patient's opinion about their knee and associated problem. The KOOS collects data on five patient-centered outcomes. The five patient-relevant subscales of KOOS are scored separately: KOOS Pain (9 items); KOOS Symptoms (7 items); KOOS ADL (17 items); KOOS Sport/Rec (5 items); KOOS QOL (4 items). A Likert scale is used and all items have five possible answer options scored from 0 (No Problems) to 4 (Extreme Problems) and each of the five scores is calculated as the sum of the items included. Scores are transformed to a 0-100 scale, with zero representing extreme knee problems and 100 representing no knee problems as is common in orthopaedic assessment scales and generic measures. Scores between 0 and 100 represent the percentage of total possible score achieved.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Knee Injury and Osteoarthritis Score (KOOS)</measure>
    <time_frame>Measured at 12 months post op</time_frame>
    <description>The Knee injury and Osteoarthritis Outcome Score (KOOS) is a patient-reported outcome measurement instrument, developed to assess the patient's opinion about their knee and associated problem. The KOOS collects data on five patient-centered outcomes. The five patient-relevant subscales of KOOS are scored separately: KOOS Pain (9 items); KOOS Symptoms (7 items); KOOS ADL (17 items); KOOS Sport/Rec (5 items); KOOS QOL (4 items). A Likert scale is used and all items have five possible answer options scored from 0 (No Problems) to 4 (Extreme Problems) and each of the five scores is calculated as the sum of the items included. Scores are transformed to a 0-100 scale, with zero representing extreme knee problems and 100 representing no knee problems as is common in orthopaedic assessment scales and generic measures. Scores between 0 and 100 represent the percentage of total possible score achieved.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Knee Injury and Osteoarthritis Score (KOOS)</measure>
    <time_frame>Measured at 24 months post op</time_frame>
    <description>The Knee injury and Osteoarthritis Outcome Score (KOOS) is a patient-reported outcome measurement instrument, developed to assess the patient's opinion about their knee and associated problem. The KOOS collects data on five patient-centered outcomes. The five patient-relevant subscales of KOOS are scored separately: KOOS Pain (9 items); KOOS Symptoms (7 items); KOOS ADL (17 items); KOOS Sport/Rec (5 items); KOOS QOL (4 items). A Likert scale is used and all items have five possible answer options scored from 0 (No Problems) to 4 (Extreme Problems) and each of the five scores is calculated as the sum of the items included. Scores are transformed to a 0-100 scale, with zero representing extreme knee problems and 100 representing no knee problems as is common in orthopaedic assessment scales and generic measures. Scores between 0 and 100 represent the percentage of total possible score achieved.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>International Knee Documentation Committee (IKDC)</measure>
    <time_frame>Measured at 3 months post op</time_frame>
    <description>The International Knee Documentation Committee (IKDC Questionnaire) is a knee-specific patient-reported outcome measure. The IKDC Questionnaire is a subjective scale that provides patients with an overall function score. The questionnaire looks at 3 categories: symptoms, sports activity, and knee function. Scores are obtained by summing the individual items, then transforming the crude total to a scaled number that ranges from 0 to 100. This final number is interpreted as a measure of function with higher scores representing higher levels of function.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>International Knee Documentation Committee (IKDC)</measure>
    <time_frame>Measured at 6 months post op</time_frame>
    <description>Scores are obtained by summing the individual items, then transforming the crude total to a scaled number that ranges from 0 to 100. This final number is interpreted as a measure of function with higher scores representing higher levels of function.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>International Knee Documentation Committee (IKDC)</measure>
    <time_frame>Measured at 12 months post op</time_frame>
    <description>Scores are obtained by summing the individual items, then transforming the crude total to a scaled number that ranges from 0 to 100. This final number is interpreted as a measure of function with higher scores representing higher levels of function.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>International Knee Documentation Committee (IKDC)</measure>
    <time_frame>Measured at 24 months post op</time_frame>
    <description>Scores are obtained by summing the individual items, then transforming the crude total to a scaled number that ranges from 0 to 100. This final number is interpreted as a measure of function with higher scores representing higher levels of function.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>LSI-Limb Symmetry Index</measure>
    <time_frame>Measured at 3 months post op</time_frame>
    <description>The Limb Symmetry Index (LSI) is a guide to objectively determine discrepancies in lower limb strength, function, and mobility. The LSI is calculated by taking the average of any test scores for the affected limb, divided by the unaffected limb, multiplied by 100 to obtain a percentage difference between limbs. A result of 100 indicated identical performance between each leg, while a result sof 50 indicates the affected leg performed half as well as the uninjured leg. Tests include single leg hop for distance, triple hop for distance, crossover hop distance, 6 meter hop for time, and isometric quadriceps strength.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>LSI-Limb Symmetry Index</measure>
    <time_frame>Measured at 6 months post op</time_frame>
    <description>The Limb Symmetry Index (LSI) is a guide to objectively determine discrepancies in lower limb strength, function, and mobility. The LSI is calculated by taking the average of any test scores for the affected limb, divided by the unaffected limb, multiplied by 100 to obtain a percentage difference between limbs. A result of 100 indicated identical performance between each leg, while a result sof 50 indicates the affected leg performed half as well as the uninjured leg. Tests include single leg hop for distance, triple hop for distance, crossover hop distance, 6 meter hop for time, and isometric quadriceps strength.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>LSI-Limb Symmetry Index</measure>
    <time_frame>Measured at 12 months post op</time_frame>
    <description>The Limb Symmetry Index (LSI) is a guide to objectively determine discrepancies in lower limb strength, function, and mobility. The LSI is calculated by taking the average of any test scores for the affected limb, divided by the unaffected limb, multiplied by 100 to obtain a percentage difference between limbs. A result of 100 indicated identical performance between each leg, while a result sof 50 indicates the affected leg performed half as well as the uninjured leg. Tests include single leg hop for distance, triple hop for distance, crossover hop distance, 6 meter hop for time, and isometric quadriceps strength.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Return to play</measure>
    <time_frame>Up to one year</time_frame>
    <description>Time from initial surgery to the patient being cleared to return to all activities they were participating in before surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adverse Effects</measure>
    <time_frame>Tracked from initiation of therapy 2 weeks post-op through 16 weeks post-op</time_frame>
    <description>Observation of any adverse events associated with BFR therapy, such as numbness, cuff-site pain, and bruising.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Anterior Cruciate Ligament Rupture</condition>
  <arm_group>
    <arm_group_label>BFR Therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group will undergo physical therapy exercises per the standard of care, with the addition of Blood Flow Restriction (BFR) utilizing a wide pressure cuff.. BFR exercises will be initiated two weeks post-op, and continued for 16 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No BFR</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group of patients will undergo physical therapy exercises per the current standard of care after their ACL reconstruction without BFR</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Blood Flow Restriction Therapy</intervention_name>
    <description>A wide pressure cuff will be applied to the upper thigh prior to starting strengthening exercises. The cuff is inflated to 80% of resting systolic blood pressure. The cuff remains inflated for the entirety of the exercise (4 sets of a specific movement). Once teh exercises are completed, it is deflated for a minimum of one minute before the next type of exercises are started.</description>
    <arm_group_label>BFR Therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>ACL Reconstruction rehabilitation</intervention_name>
    <description>post-operative rehabilitation according to current standards of care</description>
    <arm_group_label>BFR Therapy</arm_group_label>
    <arm_group_label>No BFR</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age 13-35 years at the time of surgery

          2. ACL reconstruction

          3. Using an Inova affiliated physical therapy practice for rehabilitation

        Exclusion Criteria:

          1. Concomitant ligament reconstruction

          2. Concurrent procedures that require delayed weight bearing (ie: HTO, multiligament
             reconstruction, microfracture, etc)

          3. History of DVT/PE

          4. Immunocompromising conditions (ie: Rheumatoid arthritis, chronic steroid use, etc.)

          5. History of coagulation disorders or current use of anticoagulants

          6. Completion of physical therapy at a location not affiliated with the study

          7. Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>13 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Edward Chang, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Orthopedic Surgeon</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Caroline M Fryar, MS</last_name>
    <phone>703-970-6419</phone>
    <email>caroline.fryar@inova.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Inova Health System</name>
      <address>
        <city>Fairfax</city>
        <state>Virginia</state>
        <zip>22031</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edward Chang, MD</last_name>
      <phone>201-925-6729</phone>
      <email>edward.chang@inova.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Yasuda T, Brechue WF, Fujita T, Shirakawa J, Sato Y, Abe T. Muscle activation during low-intensity muscle contractions with restricted blood flow. J Sports Sci. 2009 Mar;27(5):479-89. doi: 10.1080/02640410802626567.</citation>
    <PMID>19253083</PMID>
  </reference>
  <results_reference>
    <citation>Hughes L, Paton B, Rosenblatt B, Gissane C, Patterson SD. Blood flow restriction training in clinical musculoskeletal rehabilitation: a systematic review and meta-analysis. Br J Sports Med. 2017 Jul;51(13):1003-1011. doi: 10.1136/bjsports-2016-097071. Epub 2017 Mar 4. Review.</citation>
    <PMID>28259850</PMID>
  </results_reference>
  <results_reference>
    <citation>Iversen E, RÃ¸stad V, Larmo A. Intermittent blood flow restriction does not reduce atrophy following anterior cruciate ligament reconstruction. J Sport Health Sci. 2016 Mar;5(1):115-118. doi: 10.1016/j.jshs.2014.12.005. Epub 2015 Apr 18.</citation>
    <PMID>30356481</PMID>
  </results_reference>
  <results_reference>
    <citation>Ohta H, Kurosawa H, Ikeda H, Iwase Y, Satou N, Nakamura S. Low-load resistance muscular training with moderate restriction of blood flow after anterior cruciate ligament reconstruction. Acta Orthop Scand. 2003 Feb;74(1):62-8.</citation>
    <PMID>12635796</PMID>
  </results_reference>
  <results_reference>
    <citation>Scott BR, Loenneke JP, Slattery KM, Dascombe BJ. Blood flow restricted exercise for athletes: A review of available evidence. J Sci Med Sport. 2016 May;19(5):360-7. doi: 10.1016/j.jsams.2015.04.014. Epub 2015 May 9. Review.</citation>
    <PMID>26118847</PMID>
  </results_reference>
  <results_reference>
    <citation>Suga T, Okita K, Takada S, Omokawa M, Kadoguchi T, Yokota T, Hirabayashi K, Takahashi M, Morita N, Horiuchi M, Kinugawa S, Tsutsui H. Effect of multiple set on intramuscular metabolic stress during low-intensity resistance exercise with blood flow restriction. Eur J Appl Physiol. 2012 Nov;112(11):3915-20. doi: 10.1007/s00421-012-2377-x. Epub 2012 Mar 14.</citation>
    <PMID>22415101</PMID>
  </results_reference>
  <results_reference>
    <citation>Takada S, Okita K, Suga T, Omokawa M, Morita N, Horiuchi M, Kadoguchi T, Takahashi M, Hirabayashi K, Yokota T, Kinugawa S, Tsutsui H. Blood flow restriction exercise in sprinters and endurance runners. Med Sci Sports Exerc. 2012 Mar;44(3):413-9. doi: 10.1249/MSS.0b013e31822f39b3.</citation>
    <PMID>21795999</PMID>
  </results_reference>
  <results_reference>
    <citation>Takarada Y, Takazawa H, Sato Y, Takebayashi S, Tanaka Y, Ishii N. Effects of resistance exercise combined with moderate vascular occlusion on muscular function in humans. J Appl Physiol (1985). 2000 Jun;88(6):2097-106.</citation>
    <PMID>10846023</PMID>
  </results_reference>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>November 14, 2018</study_first_submitted>
  <study_first_submitted_qc>November 28, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 29, 2018</study_first_posted>
  <last_update_submitted>May 1, 2019</last_update_submitted>
  <last_update_submitted_qc>May 1, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 3, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Inova Health Care Services</investigator_affiliation>
    <investigator_full_name>Edward Chang, MD</investigator_full_name>
    <investigator_title>Orthopedic Surgeon</investigator_title>
  </responsible_party>
  <keyword>BFR</keyword>
  <keyword>ACL</keyword>
  <keyword>rehabilitation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rupture</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

